Platelet-Rich Plasma CPT
- PRP is considered experimental and not currently reimbursed by third party payers.
- Defined as autologous blood with concentrations of platelets above baseline values
- Autologous anti-coagulated blood is centrifuged into platelet rich and platelet poor portions. PRP can be given with or without activation. Combing PRP with calcium chloride or thrombin immediately before injection "activitates" it by inititiating platelet activation, clot formation, and growth factor release.
- Growth factors in PRP: platelet-derived growth factor, vascular endothelial growth factor, TGF-B1, fibroblast growth factor, epidermal growth factor, hepatocyte growth factor, insulin-like growth factor-1
Platelet-Rich Plasma Indications
Platelet-Rich Plasma Contraindications
- Concurrent anticoagulant use
- Active infection
- Tumor / Metatastic disease
Platelet-Rich Plasma Available Preparations
Platelet-Rich Plasma References
- Sanchez M, Sports Med 2009;39:345
- Hall MP, JAAOS 2009;17:602